Literature DB >> 33156580

Racial Disproportionality in Covid Clinical Trials.

Jason D Goldman1, Anu Osinusi2, Francisco M Marty3.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 33156580     DOI： 10.1056/NEJMc2029374

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  4 in total

1.  Randomized Prospective Open Label Study Shows No Impact on Clinical Outcome of Adding Losartan to Hospitalized COVID-19 Patients with Mild Hypoxemia.

Authors:  Matthew Geriak; Fadi Haddad; Ravina Kullar; Kristina L Greenwood; MacKenzie Habib; Cole Habib; David Willms; George Sakoulas
Journal:  Infect Dis Ther       Date:  2021-05-11

2.  DGI recommendations for COVID-19 pharmacotherapy.

Authors:  Jakob J Malin; Christoph D Spinner
Journal:  Infection       Date:  2020-10-19       Impact factor: 3.553

3.  Ongoing trials on COVID-19 treatments: please, don't forget Venous Thromboembolism!

Authors:  Marco Zuin; Giovanni Zuliani; Gianluca Rigatelli; Loris Roncon
Journal:  J Thromb Thrombolysis       Date:  2021-01-02       Impact factor: 2.300

4.  Key summary of German national treatment guidance for hospitalized COVID-19 patients : Key pharmacologic recommendations from a national German living guideline using an Evidence to Decision Framework (last updated 17.05.2021).

Authors:  Jakob J Malin; Christoph D Spinner; Uwe Janssens; Tobias Welte; Steffen Weber-Carstens; Gereon Schälte; Petra Gastmeier; Florian Langer; Martin Wepler; Michael Westhoff; Michael Pfeifer; Klaus F Rabe; Florian Hoffmann; Bernd W Böttiger; Julia Weinmann-Menke; Alexander Kersten; Peter Berlit; Marcin Krawczyk; Wiebke Nehls; Falk Fichtner; Sven Laudi; Miriam Stegemann; Nicole Skoetz; Monika Nothacker; Gernot Marx; Christian Karagiannidis; Stefan Kluge
Journal:  Infection       Date:  2021-07-06       Impact factor: 3.553
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.